Navigation Links
Amgen Announces Voting Results Of Annual Meeting Of Stockholders
Date:5/6/2009

THOUSAND OAKS, Calif., May 6 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN), today announced results of voting at the company's Annual Meeting of Stockholders, held at The St. Regis Hotel, San Francisco, Calif. Approximately 87.3 percent of outstanding shares were represented at the meeting.

The director nominees: David Baltimore, Frank J. Biondi, Jr., Francois de Carbonnel, Jerry D. Choate, Vance D. Coffman, Frederick W. Gluck, Frank C. Herringer, Gilbert S. Omenn, Judith C. Pelham, J. Paul Reason, Leonard D. Schaeffer and Kevin W. Sharer were each reelected to Amgen's Board of Directors, each receiving a majority of "For" votes of the votes cast. Each was elected by no less than 86.7 percent of the votes cast. With the reelection of these directors, Amgen currently has 12 directors.

With approximately 98.7 percent of "For" votes of the votes cast, stockholders ratified Ernst & Young LLP as Amgen's independent registered public accountants for the year ending Dec. 31, 2009.

Stockholders approved the Amgen 2009 Equity Incentive Plan, which authorizes the issuance of up to 100,000,000 shares of Amgen common stock. The proposal was approved with approximately 81.2 percent of votes cast "For."

Stockholders approved the proposed amendment to the company's Restated Certificate of Incorporation, as amended, to reduce the sixty-six and two-thirds percent (66-2/3%) voting requirement in the company's Restated Certificate of Incorporation, as amended, to a simple majority voting requirement for approval of certain business combinations. Approximately 84.4 percent of the outstanding shares of our common stock were in favor of the amendment.

Stockholders approved a nonbinding resolution recommending that the company amend its Amended and Restated Bylaws, as amended, to permit holde
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
2. Preclinical Data From Amgens Oncology Pipeline to be Presented at AACR
3. Amgen to Present at the Cowen and Company Annual Healthcare Conference
4. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
5. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
6. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
7. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
8. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
9. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
10. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
11. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Cynvenio, a ... management through the genomic analysis of tumor cells in ... Finder™, a web-based cancer decision support application powered by ... with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide ...
(Date:1/15/2014)... 15, 2014 A study has been launched ... Formula 1 track could help to tackle the problem of ... Stowhealth (a GP surgery based in Stowmarket) and academics at ... Telemetry technology, which is inspired by equipment used ...
(Date:1/15/2014)... Raleigh, NC (PRWEB) January 15, 2014 ... enhancement to its Online Web Portal for Life Science organizations ... ability to specify the subject matter of their documents in ... This will help reduce time-to-delivery of translations, often a critical ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... therapy promises to be one of the most important frontiers in medicine. ... seems to hold significant potential in terms of developing such approaches. By ... $484 million. , ... San Jose, CA (PRWEB) November 4, 2008 -- ...
... which way you look at it, the notion of harvesting ... is more absorbing than ever. , Researchers at Rensselaer Polytechnic ... two major hurdles facing solar energy. By developing a new ... solar panels and allows those panels to absorb the entire ...
... Mich., Nov. 3 Diplomat Specialty Pharmacy,today announced ... company,s executive,management team. Dr. Patel will serve as ... responsible for the management and development,of Diplomat,s Chicago ... to develop and implement specialty pharmacy programs. Dr.,Patel ...
Cached Biology Technology:World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc. 2World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc. 3Solar power game-changer: 'Near perfect' absorption of sunlight, from all angles 2Solar power game-changer: 'Near perfect' absorption of sunlight, from all angles 3Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations 2
(Date:4/18/2014)... A team of researchers led by a University of ... receive a $7.5 million Department of Defense grant to ... scientific foundations for the predictable design of light-weight, tough ... of structures from plants and animals, including the mantis ... biological systems have constructed over millions of years and ...
(Date:4/17/2014)... drug under clinical trials to treat tuberculosis could be ... act against various bacteria, fungal infections and parasites, yet ... Illinois chemists and collaborators. , Led by U. of ... different ways the drug SQ109 attacks the tuberculosis bacterium, ... pathogens from yeast to malaria and how targeting ...
(Date:4/17/2014)... word for chili peppers. Information about archaeological remains of ... of the appearance of words for chili peppers in ... domesticated and highlight the value of multi-proxy data analysis. ... of nine papers presented in a special feature issue ... Sciences on plant and animal domestication edited by ...
Breaking Biology News(10 mins):Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3
... identify potential genetic regulators in planarian stem cells, Whitehead ... the two main functions of stem cells. Three of ... proteins similar to those known to regulate mammalian embryonic ... more attractive model for studying stem cell biology in ...
... Ice Age bones indicate that humans in Ohio hunted or ... curator of archaeology at The Cleveland Museum of Natural History, ... 2012 online issue of the journal World Archaeology . ... 1998 in the collections of the Firelands Historical Society Museum ...
... dozen years, scientists have known that minuscule strings of genetic material ... finding out what they do hasn,t been easy. Now a scientist ... to turn off small RNAs and find out just how important ... just the half of it. What we are is also driven ...
Cached Biology News:Planarian genes that control stem cell biology identified 2Planarian genes that control stem cell biology identified 3Research reveals first evidence of hunting by prehistoric Ohioans 2Turning off small RNA 2
Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Request Info...
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Human acetylcholine receptor (AChR)-alpha. Exhibits homogenous, high affinity,binding to the receptor. Binds weakly to a64-78. Inhibits binding of many,myasthenia gravis sera to human AChR....
Biology Products: